Asahi Kasei Buys External Defibrillator Maker Zoll To Build Critical Care Biz
This article was originally published in PharmAsia News
Deal worth $2.2 billion builds on Japan distribution deal for Zoll’s AED Plus defibrillator, inked last summer.
You may also be interested in...
Industry survey outlines challenges of globalization cited by medtech execs, including potential for insufficient supply chain visibility. Report suggests IT improvements and “on-demand visibility” solutions could help iron out the kinks.
Written comments were due May 7 on the Internal Revenue Service’s proposed regulation to implement a 2.3% excise tax on device sales in the lead-up to a May 16 public hearing.
The findings come from two studies, including the randomized STAMPEDE trial, funded by Johnson & Johnson and the National Institutes of Health, comparing medical therapy with two forms of surgical treatment – gastric bypass or sleeve gastrectomy.